VAISHALI PHARMA
Back to Income Statement
|
VAISHALI PHARMA Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹86 Cr | ₹70 Cr | ₹76 Cr | ₹5,377,389 Cr | ₹60 Cr |
What is the latest Revenue of VAISHALI PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹70 Cr |
| Mar2023 | ₹76 Cr |
| Mar2022 | ₹5,377,389 Cr |
| Mar2021 | ₹60 Cr |
How is Revenue of VAISHALI PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹86 Cr | 23.85 | |
| Mar2024 | ₹70 Cr | -8.12 | |
| Mar2023 | ₹76 Cr | -100.00 | |
| Mar2022 | ₹5,377,389 Cr | 8,949,387.00 | |
| Mar2021 | ₹60 Cr | - | |
Compare Revenue of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹91.0 Cr | -9.6% | -12.6% | -52.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -9.6% |
-12.6% |
-52.2% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses